Accès à distance ? S'identifier sur le proxy UCLouvain
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
Primary tabs
Document type | Article de périodique (Journal article) – Clinical Trial, Clinical Trial, Phase IV, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
---|---|
Access type | Accès restreint |
Publication date | 2005 |
Language | Anglais |
Journal information | "New England Journal of Medicine" - Vol. 353, no. 13, p. 1332-1341 (2005) |
Peer reviewed | yes |
Publisher | Massachusetts Medical Society |
issn | 0028-4793 |
e-issn | 1533-4406 |
Publication status | Publié |
Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/MINT - Département de médecine interne UCL - (SLuc) Service de soins intensifs |
MESH Subject | Treatment Failure ; Survival Analysis ; Sepsis - classification - drug therapy - mortality ; Risk Factors ; Recombinant Proteins - adverse effects - therapeutic use ; Protein C - adverse effects - therapeutic use ; Prospective Studies ; Middle Aged ; Male ; Infusions, Intravenous ; Humans ; Hospital Mortality ; Hemorrhage - chemically induced ; Female ; Double-Blind Method ; Anti-Infective Agents - adverse effects - therapeutic use ; APACHE |
Links |
Bibliographic reference | Abraham, Edward ; Laterre, Pierre-François ; Garg, R ; Levy, H ; Talwar, D ; et. al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. In: New England Journal of Medicine, Vol. 353, no. 13, p. 1332-1341 (2005) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/39103 |